Cancer stem cells and tumor angiogenesis

Cancer Letters

Volumn 321, Issue 1, 2012, Pages 13-17

  Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Cancer stem cell; Tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN 4; CD133 ANTIGEN; CD24 ANTIGEN; CD44 ANTIBODY; CXCR4 ANTIBODY; CYTARABINE; HERMES ANTIGEN; IMATINIB; METHOTREXATE; MONOCLONAL ANTIBODY; RETINOIC ACID; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CANCER STEM CELL PLASTICITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CELL RENEWAL; CHRONIC MYELOID LEUKEMIA; DRUG RESISTANCE; ENDOTHELIUM CELL; HUMAN; LEUKEMIA; MONOTHERAPY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RADIOSENSITIVITY; SHORT SURVEY; STEM CELL NICHE; TUMOR ANGIOGENESIS; TUMOR MICROENVIRONMENT;

EID: 84860332933     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.024     Document Type: Review

References (55)

1. Virchow R. Editorial, archive four patologische anatomies und physiologies und four klinische. Medizin 1855, 8:23.
2. Cohnheim R. Umber entzundung und entering. Path. Anat. Physiol. Klin. Med. 1867, 40:1-79.
3. Wilms M. Die mischgeschwuelste. Leipzig Arthur George 1899.
4. Cushing H., Wolback S.B. The transformation of a malignant paravertebral sympathioblastoma into a benign ganglioneuroma. Am. J. Pathol. 1927, 3:203-216.
5. Jr Pierce G.B., Dixon F.J., Verney E.L. Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies. Lab. Invest. 1960, 9:583-602.
6. Lapidot T., Sirad C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
7. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
8. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
9. Scharenberg C.W., Harkey M.A., Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immune human hematopoietic progenitors. Blood 2002, 99:507-512.
10. Al Hajj M., Vicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
11. Nicolis S.K. Cancer stem cells and " stemless" genes in neuro-oncology. Neurobiol. Dis. 2007, 25:217-229.
12. Shmelkov S.V., St Clair R., Lyden D., Rafii S. AC133/CD133/Prominin-1. Int. J. Biochem. Cell. Biol. 2005, 37:715-719.
13. Boman B.M., Wicha M.S. Cancer stem cells: a step toward the cure. J. Clin. Oncol. 2008, 17:2795-2799.
14. Wicha M.S., Liu S S., Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 2006, 66:1883-1890.
15. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 2007, 58:267-284.
16. J. Ke, X. Wu, X. He, L. Lian, Y. Zou, X. He, H. Wang, Y. Luo, L. Wang, P. Lan, A subpopulation of CD24+ cells in colon cancer cell lines possess stem cell characteristics, Neoplasma February 14 (2012) (Epub ahead of print).
17. Y. Zhang, J. Wei, H. Wang, X. Xu, Y. An, D. Tang, Z. Yuan, F. Wang, J. Wu, J. Zhang, Y. Miao, Epithelial mesenchymal transition correlates with CD24+ CD44+ and CD133+ cells in pancreatic cancer, Oncol. Rep. February 7 (2012) (Epub ahead of print).
18. Ding X.W., Wu J.H., Jiang C.P. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010, 86:631-637.
19. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
20. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
21. Furth J., Kahn M.C. The transmission of leukemia of mice with a single cell. Am. J. Cancer. 1937, 31:276-282.
22. Makino S., Kano K. Cytological studies of tumors. XIV. Isolation of single-cell clones from a mixed tumor of the rat. J. Natl. Cancer Inst. 1955, 15:1165-1181.
23. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
24. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007, 317:337.
25. Guo W., Lasky J.L., Chang C.J., Mosessian S., Lewis X., Xiao Y., Yeh J.E., Chen J.Y., Iruela-Arispe M.L., Varella-Garcia M., Wu H. Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 2008, 453:529-533.
26. Morrison S.J., Kimbe J. Asymmetric and symmetric stem-cell division in development and cancer. Nature 2006, 441:1068-1074.
27. Balic M., Lin H., Young L., Hawes D., Giuliano A., McNamara G., Datar R.H., Cote R.J. Most early disseminated cancer cells detected in the bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res. 2006, 12:5615-5621.
28. Hermann P.C., Huber S.L., Herrler T., Aicher A., Ellwart J.W., Guba M., Bruns C.J., Heeschen C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
29. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumor formation by single human melanoma cells. Nature 2008, 456:593-598.
30. Frank N.Y., Schatton T., Frank M.H. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 2010, 120:41-50.
31. Galli R., Binda E., Orfanelli U., Cipelletti B., Critti A., De Vittis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
32. Sakariassen P.O., Prestegarden L., Wang J., Skaftnesmo K.O., Mahesparan R., Molthoff C., Sminia P., Sundlisaeter E., Misra A., Tysnes B.B., CChekenya M., Peters H., Lende G., Kalland K.H., Oyan A.M., Petersen K., Jonhassen I., van der Kogel A., Feuerstein B.G., Terzis A.J., Bjerkvig R., Enger P.O. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc. Natl. Acad. Sci. USA 2006, 103:16466-16471.
33. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11:69-82.
34. Stupp R., Hegi M.E. Targeting brain-tumor stem cells. Nat. Biotechnol. 2007, 25:193-194.
35. Ricci-Vitiani L., Pollini R., Biffoni M., Todato M., Invernici G., Cenci T., Maira G., Parati E.A., Stassi G., Larocca L.M., De Maria R. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010, 468:824-828.
36. Wang R., Chadalovada K., Wilshire J., Kowalik U., Hovinga K.E., Geber A., Fligelman B., Leversha M., Brennan C., Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature 2010, 468:829-833.
37. Bao S.D., Wu Q.L., Sathornsumetee S., Hao Y.L., Li Z.Z., Hjelmeland A.B., Shi O., McLendon R.E., Bigner D.D., Rich J.N. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006, 66:7843-7848.
38. Wilson A., Trumpp A. Bone-marrow hematopoietic-stem-cell niches. Nat. Rev. Immunol. 2006, 6:93-106.
39. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., Scadden D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
40. Avecilla S.T., Hattori K., Heissig B., Tejada R., Liao F., Shido K., Jin D.D.K., Dias S., Zhang F., Hartman T.T.E., Hackett N.R., Crystal R.G., Witte L., Hicklin D.J., Bohlen P., Eaton D., Lyden D., de Sauvage F., Rafii S. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med. 2004, 10:64-71.
41. Kopp H.G., Avecilla S.T., Hooper A.T., Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology 2005, 20:349-356.
42. Butler J.M., Kobayashi H., Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat. Rev. Cancer 2010, 10:138-146.
43. Folkins S., Shked Y., Man S., Tang T., Lee C.R., Zhu Z.P., Hoffman R.M., Kerbel R.S. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res. 2009, 69:7243-7251.
44. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replacing in vivo. J. Exp. Med. 1996, 183:1797-1806.
45. Wulf G.G., Wang R.Y., Kuchnke I., Weidner D., Marini F., Brenner M.K., Andreeff M., Goodell M.A. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001, 98:1166-1173.
46. Deininger M., Buchdunger E., Druker B.J. The development of inatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005, 105:2640-2653.
47. + progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia 2005, 19:1034-1041.
48. Jin L., Hope K.J., Zhai Q., Smadja-Joffe F., Dick J.E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 2006, 12:1167-1174.
49. Tavor S., Petit I., Porozov S., Avigdor A., Dar A., Leider-Trejo L., Shemtov N., Deutsch V., Naparstek E., Nagler A., Lapidot T. CXCR4 regulates migration and development of human acute myelogeneous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res. 2004, 64:2817-2824.
50. Piccirillo S.G., Reynolds B.A., Zanetti N., Lamorte G., Binda E., Brogli G., Brem H., Olivi A., Dimeco F., Vescovi A.L. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour infiltrating cells. Nature 2006, 444:761-765.
51. Hovinga K.E., Shimizu F., Wang R., Panagiotakos G., Vander Heijden M., Moayedpardazi H., Sofia Correia A., Soulet D., Major T., Menon J., Tabar V. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem cells 2010, 28:1019-1029.
52. Spira A.I., Carducci M.A. Differentiation therapy. Curr. Opin. Pharmacol. 2003, 3:338-343.
53. Camacho L.H. Clinical application of retinoids in cancer medicine. J. Biol. Regul. Homeost. Agents 2003, 17:98-114.
54. Ohno R., Asou N., Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia 2003, 17:1454-1463.
55. Andreeff M., Jiang S., Zhang X., Konopleva M., Estrov Z., Snell V.E., Xie Z., Okcu M.F., Sanchez-Williams G., Dong J., Estey E.H., Champlin R.C., Komblau S.M., Reed J.C., Zhao S. Expression of bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid. Leukemia 1999, 13:1881-1892.